Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

345ae6684d4d9b5e22d89af552bc8d.3djOrVJHAT6ngXToCnOd7LjOezh8v3RxjwyMMUgoORE.qpqR5j5wLG3k2DCiYBatvtH3IWAM7S4J9mG1cyN7W1KIlr38NQ03R_fyLQ~a3db9ba975d8c989b68be4bff5dd64cb
23/09 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
22/09 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
09/09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
27/07 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
27/07 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
24/07 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
24/07 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
24/07 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
20/07 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
16/07 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
14/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
13/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
10/07 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
06/07 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
02/07 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
09/06 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
28/05 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
25/04 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
24/04 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
24/04 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
24/04 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
24/04 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT
24/04 Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating MT
24/04 TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating MT
24/04 Analyst recommendations: IBM, Intel, Tesla, AMD, United Rentals… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.73%
+18.27%
+20.31%
+6.44%
+28.59%
+9.07%
+28.35%
+10.02%
+10.88%
Average +16.74%
Weighted average by Cap. +17.81%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
370.44USD
Average target price
407.56USD
Spread / Average Target
+10.02%
High Price Target
459.00USD
Spread / Highest target
+23.91%
Low Price Target
340.00USD
Spread / Lowest Target
-8.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WPS Stock
  5. Consensus West Pharmaceutical Services, Inc.